£515.00

The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in India

Price data last checked 84 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 7 days • 7 data points (No recent data available)

Historical
Generating forecast...
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 26 January 2026 27 January 2026 29 January 2026 30 January 2026 01 February 2026

Price Distribution

Price distribution over 7 days • 1 price levels

Days at Price
7 days 0 2 4 5 7 £515 Days at Price

Price Analysis

Most common price: £515 (7 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 7 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
28 September 2022

Similar Products You Might Like

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in India
99% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Antiviral Drugs in India
98% match

The 2023-2028 Outlook for Antiviral Drugs in India

£515.00 29 Jan 2026
The 2023-2028 Outlook for Anti-Malarial Drugs in India
98% match

The 2023-2028 Outlook for Anti-Malarial Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Over the Counter Drugs in India
97% match

The 2023-2028 Outlook for Over the Counter Drugs in India

£515.00 20 Jan 2026
The 2023-2028 Outlook for Nocturia Drugs in India
97% match

The 2023-2028 Outlook for Nocturia Drugs in India

£515.00 10 Mar 2026
The 2023-2028 Outlook for Topical Antiseptic Medications in India
97% match

The 2023-2028 Outlook for Topical Antiseptic Medications in India

£515.00 27 Jan 2026
The 2023-2028 Outlook for OTC Drugs in India
97% match

The 2023-2028 Outlook for OTC Drugs in India

£515.00 24 Jan 2026
The 2023-2028 Outlook for Lipopeptide MRSA Drugs in India
97% match

The 2023-2028 Outlook for Lipopeptide MRSA Drugs in India

£515.00 08 Feb 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in India
97% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in India

£515.00 31 Jan 2026
The 2023-2028 Outlook for Anticoagulant Drugs in India
97% match

The 2023-2028 Outlook for Anticoagulant Drugs in India

£515.00 26 Jan 2026
The 2023-2028 Outlook for Viral Infections in India
97% match

The 2023-2028 Outlook for Viral Infections in India

£515.00 28 Jan 2026
The 2023-2028 Outlook for Kinase Inhibitors in India
97% match

The 2023-2028 Outlook for Kinase Inhibitors in India

£515.00 11 Jan 2026
The 2023-2028 Outlook for Narcolepsy Drugs in India
97% match

The 2023-2028 Outlook for Narcolepsy Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Antiviral Drugs in the United States
97% match

The 2023-2028 Outlook for Antiviral Drugs in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India
97% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Topical Pain-Relieving Medications in India
97% match

The 2023-2028 Outlook for Topical Pain-Relieving Medications in India

£515.00 10 Mar 2026
The 2023-2028 Outlook for Uveitis Drugs in India
97% match

The 2023-2028 Outlook for Uveitis Drugs in India

£515.00 01 Feb 2026
The 2023-2028 Outlook for Anticoagulant Reversal Drugs in India
97% match

The 2023-2028 Outlook for Anticoagulant Reversal Drugs in India

£515.00 20 Apr 2026
The 2023-2028 Outlook for Erythropoietin Drugs in India
97% match

The 2023-2028 Outlook for Erythropoietin Drugs in India

£515.00 10 Dec 2025
The 2023-2028 Outlook for Topical Antifungal Medications in India
97% match

The 2023-2028 Outlook for Topical Antifungal Medications in India

£515.00 10 Dec 2025
The 2023-2028 Outlook for Insomnia Drugs in India
97% match

The 2023-2028 Outlook for Insomnia Drugs in India

£515.00 21 Jan 2026
The 2023-2028 Outlook for COVID-19 Vaccines in India
97% match

The 2023-2028 Outlook for COVID-19 Vaccines in India

£515.00 24 Jan 2026
The 2023-2028 Outlook for HIV and AIDS Therapeutics in India
97% match

The 2023-2028 Outlook for HIV and AIDS Therapeutics in India

£515.00 23 Jan 2026
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in India
97% match

The 2023-2028 Outlook for Natural Killer Cell Therapeutics in India

£515.00 06 Feb 2026